Skip to main content
Transgender Health logoLink to Transgender Health
. 2022 Jun 13;7(3):230–236. doi: 10.1089/trgh.2020.0133

Disparities in Sexually Transmitted Infection Testing and the Need to Strengthen Comprehensive Sexual Health Services for Trans Women

Dillon Trujillo 1,*, Sean Arayasirikul 1,2,3, Hui Xie 1, Sofia Sicro 1, Joaquin Meza 1, Mackie Bella 1, Emperatriz Daza 1, Francisco Torres 1, Willi McFarland 1,4, Erin C Wilson 1,4
PMCID: PMC9829146  PMID: 36643058

Abstract

Purpose:

Few studies have examined the importance of improving the sexual health delivery system beyond HIV among trans women. We assessed survey data from the National HIV Behavioral Surveillance Transgender Woman (NHBS-Trans) Study in San Francisco to characterize the utilization of sexual health services among HIV-negative trans women and to explore opportunities to improve sexual health services for trans women.

Methods:

Trans women were recruited through respondent-driven sampling from July 2019 to February 2020. The analytic sample was restricted to 116 HIV-negative trans women. We identified trends in data using chi-squared tests to assess significance between sexual risk behavior and the use of preventative sexual health services and built logistic regression models to assess the relationships between sexual risk behaviors and sexually transmitted infection (STI) testing.

Results:

The majority of sample was trans women of color with most identifying as Latinx (42.2%). Over half were low income (56%), and majority had been homeless in past 12 months (62.9%). The prevalence of condomless receptive anal sex was 52.6% with about two-thirds (62.1%) recently having an STI test. Participants who engaged in recent condomless receptive anal sex had more than fivefold greater odds of having a recent STI test compared to their counterparts who did not (adjusted odds ratio [aOR] 5.60, 95% confidence interval [CI] 1.83–17.11; p=0.003). We also found age- and education-related disparities in STI testing.

Conclusion:

This study characterized the utilization of sexual health services among HIV-negative trans women and identified important disparities in STI testing. We discuss opportunities to strengthen sexual health care delivery systems.

Keywords: HIV/AIDS, sexual health, sexually transmitted infections (STIs), transgender women

Introduction

A recent systematic review found that globally trans women have a high prevalence of HIV and are at increased risk for other sexually transmitted infections (STIs) such as gonorrhea and chlamydia.1 Overall, trans women are at greater risk for STIs compared to their cisgender counterparts.2,3 For example, in Los Angeles, California, one study found that STI positivity was 25% among trans women compared to 11% among cisgender women and 15% among heterosexual cisgender men.4 Data on STIs other than HIV among trans women in the United States are limited, in part, because national surveillance systems do not capture trans women in their data. For example, Centers for Disease Control and Prevention (CDC) STI surveillance data only record cisgender men and women genders, erasing important sexual health indicators for transgender populations.5 To date, what we know about STIs among trans women is limited to secondary data from studies conducted primarily with trans women using convenience sampling. The gap in data prevents the public health system from having a full and accurate picture of sexual health indicators in the United States and perpetuates disparities for gender minorities like trans women.4,6,7

Stigma and transphobia exacerbate negative health outcomes among trans women.8–10 Globally, trans people face higher levels of stigma and discrimination due to the lack of social and legal recognition of their gender identity and systemic exclusion from critical social institutions like employment and education.11 Transphobic stigma and discrimination in medical settings prevent trans women from accessing preventive health services and care.6,12,13 The rights of trans people in the United States are under attack with the Trump Administration attempting to remove protections for trans people in the Patient Protection and Affordable Care Act (ACA).14 As a result, trans women, particularly trans women of color, will face even more social and structural barriers that will prevent them from accessing and utilizing critical preventative sexual health services.6,15,16

We must also consider how HIV disparities frame how trans women engage with the sexual health delivery system. People living with HIV (PLWH) have a higher prevalence of STIs compared to those who are HIV negative.17 In San Francisco, trans women are consistently estimated to have a higher prevalence of HIV compared to other key populations with young trans women aged 18–24 years old having significantly higher HIV incident rates compared to those 25 and older.18,19 Promoting and expanding STI screenings in community settings is a key strategy for health departments to improve the utilization of sexual health services among those most at-risk for STIs. Despite the growing amount of evidence for STI risk among trans women, there are notable gaps in the literature on STI surveillance data and more specifically the factors related to poor STI testing in cities where there is optimal HIV testing coverage. The majority of incidence estimates are all based on convenience samples rather than locally or nationally representative samples. Therefore, it is imperative that local, state, and national health jurisdictions include gender identity with STI reporting and expand STI testing efforts among trans women. These improvements will support our ability to develop and implement effective prevention programs and comprehensive sexual health interventions.

This analysis uses data from the San Francisco site of the NHBS-Trans Study to characterize the utilization of sexual health services among HIV-negative trans women in our city. We analyzed a sociobehavioral survey to explore priorities and opportunities to improve sexual health services for trans women. Few studies, if any, have explored the importance of improving sexual health services and resources for trans women beyond HIV/AIDS.

Methods

Sample and procedures

The present study analyzes data from the first NHBS study conducted with trans women residing in San Francisco, collected between July 2019 and February 2020. NHBS methods have been described in detail elsewhere.20 Briefly, trans women were recruited using respondent-driven sampling (RDS). RDS has been used as a method to sample hidden populations beyond those seen at services or venues using peer networks to refer participants.21,22 During our formative research phase, we identified 25 “seeds,” eligible trans women from diverse social networks who recruited three to five other trans women from their social networks after participating in the study. Eligible participants were: (1) 18 years or older; (2) self-identified as trans women; (3) fluent in English or Spanish; and (4) residents of San Francisco. Participants provided informed consent and completed a face-to-face, interviewer administered survey. They were offered a free rapid HIV test and tests for STI and HCV. Participants received a total of $100 for completing all study activities and an additional $25 for each eligible peer referral enrolled in the study. The study was approved by the Institutional Review Board (IRB) of the University of California, San Francisco.

Measures

The following demographic characteristics were assessed: age, race/ethnicity, education, income, employment status, history of homelessness, and current housing status. We measured engagement in sexual risk behaviors in the past 12 months by asking participants the following questions: In the past 12 months, have you had receptive anal sex without a condom? In the past 12 months, have you had receptive vaginal sex without a condom? In the past 12 months, have you had insertive anal sex without a condom? In the past 12 months, have you had insertive vaginal sex without a condom? We dichotomized each of these items (yes/no).

To characterize utilization of preventive sexual health services, we used seven measures, spanning testing, preventive behaviors, and biomedical prevention. We measured recent HIV testing by asking participants if they had ever had an HIV test (yes/no). We asked those who had ever had an HIV test, “Was your most recent HIV test in the past 12 months (yes/no)?” We measured recent STI testing by asking participants, “In the past 12 months, were you tested by a doctor or other health care provider for a sexually transmitted disease like gonorrhea, chlamydia, or syphilis (yes/no)?” We measured recent participation in HIV prevention activities by asking participants, “In the past 12 months, have you had a one-on-one conversation with an outreach worker, counselor, prevention program worker, or participated in an organized group session to discuss ways to prevent HIV infections (yes/no)?” We measured utilization of free condom distribution services by asking participants, “In the past 12 months, have you gotten any free condoms, not counting those given to you by a friend, relative or sex partner?”

Analysis

This analysis is focused on sexual health service utilization, which includes primary HIV prevention. As a result, we restricted the analytic sample to 116 trans women who were HIV negative, excluding participants who had self-reported living with HIV or had a reactive rapid HIV test result. Descriptive statistics was used to characterize overall demographics, sexual risk behaviors, and use of preventive sexual health services. To assess the bivariate relationships between sexual risk behaviors and use of preventive sexual health services, we used chi-square tests and a cutoff level of 0.05 for statistical significance. We then built logistic regression models for sexual health service outcomes that were statistically significant at the bivariate level. Analyses were conducted using STATA 16.23

Results

Sample characteristics of 116 HIV-negative trans women are presented in Table 1. Over 30% (32.8%) of participants were 50 years old or older. A plurality were Latinx (42.2%, n=49); the majority were non-White. Almost half of participants reported having a high school diploma or less (49.1%, n=57), and more than half reported an annual income below the federal poverty level or $12,490 in 2019 (56.0%, n=65). A majority had been homeless in the past 12 months (62.9%, n=73) and about one-fourth were currently experiencing homelessness (26.7%, n=31). In terms of recent sexual risk behavior, participants frequently reported condomless receptive anal sex (52.6%, n=61), followed by condomless insertive anal sex (20.7%, n=24), condomless insertive vaginal sex (8.6%, n=10), and receptive vaginal sex (6.0%, n=7) in the last 12 months. A large majority reported recently having an HIV test (87.9%, n=102) and receiving free condoms (81.9%, n=95). About two-thirds of participants reported recently having an STI test (62.1%, n=72) and participated in a HIV prevention activity (64.7%, n=75).

Table 1.

Demographic Characteristics and Structural Determinants of Health Among HIV-Negative Trans Women, San Francisco, 2019 (N=116)

  Overall
n %
Demographics
Age
 18–29 22 19.0
 30–39 25 21.6
 40–49 31 26.7
 50+ 38 32.8
Race/ethnicity
 White 26 22.4
 African American/Black 14 12.1
 Latinx 49 42.2
 NH-Asian and Pacific Islander 10 8.6
 Other 17 14.7
Education
 HS diploma or less 57 49.1
 Some college 39 33.6
 Bachelor's degree or more 20 17.2
Annual income
 Below federal poverty level ($12,490 or less) 65 56.0
 Above federal poverty level (more than $12,490) 51 44.0
Employment status
 Full-time 16 13.8
 Part-time 15 12.9
 Unemployed or other 85 73.3
History of homelessness (last 12 months)
 No 43 37.1
 Yes 73 62.9
Currently experiencing homelessness
 No 85 73.3
 Yes 31 26.7
Sexual risk behaviors
Condomless receptive anal sex (last 12 months)
 No 55 47.4
 Yes 61 52.6
Condomless receptive vaginal sex (last 12 months)
 No 109 94.0
 Yes 7 6.0
Condomless insertive anal sex (last 12 months)
 No 92 79.3
 Yes 24 20.7
Condomless insertive vaginal sex (last 12 months)
 No 106 91.4
 Yes 10 8.6
Use of preventive sexual health services
Recent HIV test (last 12 months)
 No 14 12.1
 Yes 102 87.9
Recent STI test (last 12 months)
 No 44 37.9
 Yes 72 62.1
Participated in HIV prevention activities (last 12 months)
 No 41 35.3
 Yes 75 64.7
Received free condoms (last 12 months)
 No 21 18.1
 Yes 95 81.9

STI, sexually transmitted infection.

Table 2 shows the relationships between sexual risk behaviors and utilization of sexual health service outcomes. Participants who engaged in recent condomless receptive anal sex were more likely to have had a recent STI test compared to those who did not (75.4% vs. 47.3%, respectively, p=0.002). In addition, participants who engaged in recent condomless insertive vaginal sex were less likely to have had a recent STI test (100% vs. 58.5%, respectively, p=0.01) compared to those that did not. There were no statistically significant differences between each sexual risk behavior and the other sexual health service outcomes.

Table 2.

Relationships Between Sexual Behaviors and Sexual Health Service Utilization Among HIV-Negative Trans Women (N=116)

  Recent HIV test
Recent STI test
Participated in HIV prevention activities
Received free condoms
No Yes χ2 p No Yes χ2 p No Yes χ2 p No Yes χ2 p
Sexual risk behaviors
Condomless receptive anal sex (last 12 months)
 No 8 (14.5) 47 (85.5) 0.6044 0.437 29 (52.7) 26 (47.3) 9.7258 0.002 23 (41.8) 32 (58.2) 1.9179 0.166 14 (25.5) 41 (74.5) 3.8121 0.051
 Yes 6 (9.8) 55 (90.2)     15 (24.6) 46 (75.4)     18 (29.5) 43 (70.5)     7 (11.5) 54 (88.5)    
Condomless receptive vaginal sex (last 12 months)
 No 14 (12.8) 95 (87.2) 1.0225 0.312 43 (39.4) 66 (60.6) 1.7691 0.183 40 (36.7) 69 (63.3) 1.4457 0.229 20 (18.3) 89 (81.7) 0.0732 0.787
 Yes 0 (0.00) 7 (6.86)     1 (14.3) 6 (85.7)     1 (14.3) 6 (85.7)     1 (14.3) 6 (85.7)    
Condomless insertive anal sex (last 12 months)
 No 9 (9.8) 83 (90.2) 2.1903 0.139 39 (42.4) 53 (57.6) 3.7574 0.053 34 (37.0) 58 (63.0) 0.5054 0.477 19 (20.7) 73 (79.3) 1.9483 0.163
 Yes 5 (20.8) 19 (79.2)     5 (11.36) 19 (26.39)     7 (17.07) 17 (22.67)     2 (9.52) 22 (23.16)    
Condomless insertive vaginal sex (last 12 months)
 No 14 (13.2) 92 (86.8) 1.502 0.220 44 (41.5) 62 (58.5) 6.6876 0.01 38 (35.8) 68 (64.2) 0.1368 0.711 19 (17.9) 87 (82.1) 0.0265 0.871
 Yes 0 (0.0) 10 (100.0)     0 (0.0) 10 (100.0)     3 (30.0) 7 (70.0)     2 (20.0) 8 (80.0)    

Table 3 shows associations with STI testing. Participants who engaged in recent condomless receptive anal sex had more than fivefold greater odds of having a recent STI test compared to their counterparts who did not (adjusted odds ratio [aOR] 5.60, 95% confidence interval [CI] 1.83–17.11; p=0.003). Participants aged 50 years or older were less likely to have a recent STI test compared to those aged 18 to 29 years (aOR 0.21, 95% CI 0.05–0.92; p=0.039). Participants with some college education were more likely to have a recent STI test compared to those with a high school diploma or less (aOR 3.90, 95% CI 1.00–15.19; p=0.050).

Table 3.

Predictors of Sexually Transmitted Infection Testing Among HIV-Negative Trans Women in San Francisco, 2019

  Recent STI test (n=106)
aOR CI p
Demographics
Age
 18–29 Ref.    
 30–39 2.57 0.43–15.32 0.301
 40–49 2.58 0.52–12.74 0.246
 50+ 0.21 0.05–0.92 0.039
Race/ethnicity
 NH-White Ref.    
 NH-African American/Black 0.19 0.03–1.31 0.092
 Latinx 1.29 0.31–5.39 0.729
 NH-Asian and Pacific Islander 0.16 0.01–1.78 0.135
 Other 1.00 0.18–5.65 0.999
Education
 HS diploma or less Ref.    
 Some college 3.90 1.00–15.19 0.050
 Bachelor's degree or more 1.74 0.37–8.13 0.483
Income
 below federal poverty level Ref.    
 above federal poverty level 2.01 0.64–6.29 0.230
Employment status
 Full-time Ref.    
 Part-time 1.36 0.17–11.07 0.772
 Unemployed or other 3.30 0.60–18.19 0.170
History of homelessness (last 12 months)
 No Ref.    
 Yes 0.66 0.18–2.47 0.540
Currently experiencing homelessness
 No Ref.    
 Yes 0.37 0.08–1.71 0.201
Sexual risk behaviors
Unprotected receptive anal sex (last 12 months)
 No Ref.    
 Yes 5.60 1.83–17.11 0.003
Unprotected receptive vaginal sex (last 12 months)
 No Ref.    
 Yes 2.91 0.19–43.88 0.441
Unprotected insertive anal sex (last 12 months)
 No Ref.    
 Yes 5.71 0.95–34.45 0.057
Unprotected insertive vaginal sex (last 12 months)
 No Ref.    
 Yes Empty    

aOR, adjusted odds ratio; CI, confidence interval.

Discussion

Our study identified potential improvements in the sexual health services delivery system for trans women in San Francisco. We found that recent HIV testing surpassed that of STI testing. This illustrates that STI screening efforts are suboptimal compared to HIV testing in San Francisco. We hypothesize that the missed opportunities to receive both an HIV test and comprehensive STI testing may be a result of the siloing of HIV and sexual health services and evidence that greater integration can be achieved. Disparities in sexual health service utilization have been shown to be linked to deficits in medical education and clinician competency in sexual and gender minority health.24 The high prevalence of sexual risk behaviors and low STI screening in combination with poor uptake in recommended sexual health prevention activities in this sample is concerning. For example, while a large majority of trans women reported to have received free condoms in the last 12 months, over half reported recent condomless receptive anal sex (52.59%, n=55). While condomless sexual risk behaviors among this sample of trans women were diverse, condomless anal sex is more frequent, especially condomless receptive anal sex presenting the highest risk of STI transmission.25,26 These findings are consistent with the data reported by the San Francisco Department of Public Health (SFDPH) that show high levels of HIV testing among groups at-risk for HIV.27 However, without comprehensive surveillance of sexual health, data on the utilization of HIV testing may not be comparable to other indicators of sexual health services.

We also found that many participants who recently engaged in condomless sex were not more likely to report utilization of several sexual health services. This finding is worrisome, as elevated rates of STI prevalence have been documented among trans women. An analysis of 292 transgender person-visits to a municipal clinic in San Francisco between 2006 and 2009 estimated an STI positivity rate ranging from 2.0% to 11.1%.28 Other studies have also found similarly high levels of STIs among trans women. For example, a San Diego study among trans men and women found 13.2% reporting having any STI, 9.9% with chlamydia, 7.3% with gonorrhea, and 26% with syphilis in the last year.29 To maximize the availability and reach of comprehensive sexual health services to trans women, a systemic approach is needed to support trans women to identify risk and utilize the appropriate sexual health services. For example, we found that structural disparities and social inequity in recent STI testing exist and may leave out older trans women and those without some college education. Future public health planning ought to consider these disparities.

There is a need for increased routine STI screening for trans women. To eliminate sexual health-related disparities, local health departments may want to consider starting with modeling sexual health services after HIV prevention services as low-hanging fruit to promote and increase the availability and reach of these services in community settings. Redefining how sexual health is operationalized beyond HIV/AIDS will be an important tool to strengthen the sexual health delivery system and support comprehensive sexual health surveillance, specifically for transgender populations. Essential to this is that routine standardized collection of gender identity data among all publicly-funded health centers who serve trans women is necessary. Rather than the dominant approach to establishing guidelines and standards of care that perpetuate system silos, comprehensive sexual health delivery systems ought to be designed with social conditions as fundamental causes of health inequalities at the center of public health.30 Fundamental causes of health inequalities as a lens can help local health departments reimagine how public health systems can be organized to address root causes of health inequity and help identify strategies that cut across multiple disease areas and social ecological factors. In studies in many parts of the United States and the world, trans women have a unique set of mental, physical, and sexual health needs that are largely shaped by living in a transphobic society that go on to prevent utilization of comprehensive sexual health services.6,9,31–35 Structural and multilevel interventions must address these social conditions as fundamental causes of inequality and the maladapted structures that contribute to inaccessible testing, diagnosis, and treatment for STIs and sexual health promotion among and for trans women.32,36,37

This study is not without limitations. Data from this study may not be generalizable to other parts of the country due to the unique trans-specific health services in San Francisco. These data were collected as part of the NHBS study where the focus was on HIV/AIDS with fewer questions on other sexual health services. A future more in-depth study on comprehensive sexual health service utilization may allow for a more nuanced understanding. In addition, this was the first cycle of NHBS that was inclusive of trans women. Although cross-sectional, the potential of future NHBS data collection cycles with trans women may address the critical gap in local and national surveillance efforts centered on the health of trans populations over time.

Conclusion

Despite limitations, this study characterized the utilization of sexual health services among HIV-negative trans women in San Francisco and identified potential gaps in the health care delivery system in San Francisco. The paucity of data regarding sexual health services and utilization among trans women is surprising, and this article addresses this gap in the literature. It underscores the significance of social conditions as fundamental causes of health inequalities and the development of trans-specific services at the local health department level. Incorporation of health service delivery models centered in an equity and social justice framework may play a critical role in the success of the disease prevention and health promotion for communities of trans women.

Acknowledgments

The authors acknowledge San Francisco participants of the NHBS-Trans Study for their time and participation.

Abbreviations Used

ACA

Affordable Care Act

aOR

adjusted odds ratio

CDC

Centers for Disease Control and Prevention

CI

confidence interval

IRB

Institutional Review Board

NHBS-Trans

National HIV Behavioral Surveillance Transgender Woman

PLWH

People living with HIV

RDS

respondent-driven sampling

SFDPH

San Francisco Department of Public Health

STI

sexually transmitted infection

Author Confirmation Statement

All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work and take responsibility for the content, including participation in the data collection, concept, design, analysis, writing, or revision of the article.

Disclaimer

The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the San Francisco Department of Public Health or the Centers for Disease Control and Prevention.

Author Disclosure Statement

No competing financial interests exist.

Funding Information

This work was supported by the Centers for Disease Control and Prevention (grant no. PS005077-02).

Cite this article as: Trujillo D, Arayasirikul S, Xie H, Sicro S, Meza J, Bella M, Daza E, Torres F, McFarland W, Wilson EC (2022) Disparities in sexually transmitted infection testing and the need to strengthen comprehensive sexual health services for trans women, Transgender Health 7:3, 230–236, DOI: 10.1089/trgh.2020.0133.

References

  • 1. MacCarthy S, Poteat T, Xia Z, et al. Current research gaps: a global systematic review of HIV and sexually transmissible infections among transgender populations. Sex Health. 2017;14:456–468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Poteat T, Reisner SL, Radix A. HIV epidemics among transgender women. Curr Opin HIV AIDS. 2014;9:168–173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Wickersham JA, Gibson BA, Bazazi AR, et al. Prevalence of human immunodeficiency virus and sexually transmitted infections among cisgender and transgender women sex workers in greater Kuala Lumpur, Malaysia: results from a Respondent-Driven Sampling Study. Sex Transm Dis. 2017;44:663–670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Shover CL, DeVost MA, Beymer MR, et al. Using sexual orientation and gender identity to monitor disparities in HIV, sexually transmitted infections, and viral hepatitis. Am J Public Health. 2018;108(S4):S277–S283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Surveillance Available at: https://www.cdc.gov/std/stats16/default.htm. Accessed March 17, 2020.
  • 6. Stroumsa D. The state of transgender health care: policy, law, and medical frameworks. Am J Public Health. 2014;104:e31–e38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Reisner SL, Radix A, Deutsch MB. Integrated and gender-affirming transgender clinical care and research. J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S235–S242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Bradford J, Reisner SL, Honnold JA, et al. Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2013;103:1820–1829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Gonzales G, Henning-Smith C. Barriers to care among transgender and gender nonconforming adults. Milbank Q. 2017;95:726–748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Lombardi EL, Wilchins RA, Priesing D, et al. Gender violence: transgender experiences with violence and discrimination. J Homosex. 2001;42:89–101. [DOI] [PubMed] [Google Scholar]
  • 11. National Center for Transgender Equality: National Transgender Discrimination Survey: Full Report. Available at: https://transequality.org/issues/resources/national-transgender-discrimination-survey-full-report. Accessed July 7, 2020.
  • 12. Jennings L, Barcelos C, McWilliams C, et al. Inequalities in lesbian, gay, bisexual, and transgender (LGBT) health and health care access and utilization in Wisconsin. Prev Med Rep. 2019;14:100864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Safer JD, Coleman E, Feldman J, et al. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016;23:168–171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Simmons-Duffin S. Transgender Health Protections Reversed By Trump Administration. Available at: https://www.npr.org/sections/health-shots/2020/06/12/868073068/transgender-health-protections-reversed-by-trump-administration. Accessed June 15, 2020.
  • 15. Lambda Legal: When health care isn't caring: Lambda Legal's survey on discrimination against LGBT people and people living with HIV. 2010. Available at https://www.lambdalegal.org/publications/when-health-care-isnt-caring. Accessed July 7, 2020.
  • 16. Beltran T, Allen AM, Lin J, et al. Intersectional discrimination is associated with housing instability among trans women living in the San Francisco Bay Area. Int J Environ Res Public Health. 2019;16:4521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Chesson HW, Heffelfinger JD, Voigt RF, et al. Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002. Sex Transm Dis. 2005;32:265–269. [DOI] [PubMed] [Google Scholar]
  • 18. Raymond HF, Wilson EC, Packer T, et al. High and stable human immunodeficiency virus prevalence among transwomen with low income recruited with respondent-driven sampling, San Francisco, 2010–2016. Sex Transm Dis. 2019;46:118–124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. McFarland W, Wesson P, Turner C, et al. High HIV incidence among young and racial/ethnic minority transgender women in San Francisco: results of a Longitudinal Cohort Study. J Acquir Immune Defic Syndr. 2020;84:e7–e10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174–199. [Google Scholar]
  • 21. Santos GM, Wilson EC, Rapues J, et al. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90:430–433. [DOI] [PubMed] [Google Scholar]
  • 22. Kral AH, Malekinejad M, Vaudrey J, et al. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health. 2010;87:839–850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC, 2019. [Google Scholar]
  • 24. Obedin-Maliver J, Goldsmith ES, Stewart L, et al. Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. JAMA. 2011;306:971–977. [DOI] [PubMed] [Google Scholar]
  • 25. Ward H, Ronn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5:305–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kelley CF, Kraft CS, de Man TJ, et al. The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention. Mucosal Immunol. 2017;10:996–1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. San Francisco Department of Public Health: HIV Epidemiology Annual Report 2018. 2018. Available at https://www.sfdph.org/dph/files/reports/RptsHIVAIDS/HIV-Epidemiology-Annual-Report-2018.pdf. Accessed July 9, 2020.
  • 28. Stephens SC, Bernstein KT, Philip SS. Male to female and female to male transgender persons have different sexual risk behaviors yet similar rates of STDs and HIV. AIDS Behav. 2011;15:683–686. [DOI] [PubMed] [Google Scholar]
  • 29. Green N, Hoenigl M, Morris S, et al. Risk behavior and sexually transmitted infections among transgender women and men undergoing community-based screening for acute and early HIV infection in San Diego. Medicine (Baltimore). 2015;94:e1830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995:80–94. [PubMed] [Google Scholar]
  • 31. Hull S, Kelley S, Clarke JL. Sexually transmitted infections: compelling case for an improved screening strategy. Popul Health Manag. 2017;20(S1):S1–S11. [PubMed] [Google Scholar]
  • 32. Pinto RM, Berringer KR, Melendez R, et al. Improving PrEP implementation through multilevel interventions: a synthesis of the literature. AIDS Behav. 2018;22:3681–3691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Luvuno ZPB, Ncama B, McHunu G. Transgender population's experiences with regard to accessing reproductive health care in Kwazulu-Natal, South Africa: a qualitative study. Afr J Prim Health Care Fam Med. 2019;11:e1–e9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Newman-Valentine D, Duma S. Injustice to transsexual women in a hetero-normative healthcare system. Afr J Prim Health Care Fam Med. 2014;6:E1–E5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Yan ZH, Lin J, Xiao WJ, et al. Identity, stigma, and HIV risk among transgender women: a qualitative study in Jiangsu Province, China. Infect Dis Poverty. 2019;8:94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Poteat T, Malik M, Scheim A, et al. HIV Prevention among transgender populations: knowledge gaps and evidence for action. Curr HIV/AIDS Rep. 2017;14:141–152. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Transgender Health are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES